Delivery Order SPE2DB24D2102-SPE2DB25FJJTX
- Not listed
- The Defense Logistics Agency awarded a $3,791.46 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3mL insulin pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3mL insulin pens, valued at $1,862.88. This firm fixed-price delivery order, which concludes on July 24, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical supply delivery. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,396.34 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3ml insulin pens. This is a firm fixed-price, non-set-aside contract with a completion date of September 10, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order valued at $1,725.61 to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3ml insulin pens on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of NovoLog Mix 70/30 FlexPen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,342.84 with an ultimate completion date of September 8, 2025. The contract represents a non-set-aside procurement issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,397 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3mL insulin pens, with completion scheduled for August 19, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3mL insulin pens, a widely-used combination insulin product for diabetes management. This firm fixed-price delivery order, valued at $1,252.30, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $5,127.04 to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3ml insulin medication. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of September 24, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order is executed...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,562.48 to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3mL insulin pens. This is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,807.97 to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3mL insulin pens on September 2, 2025, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement of pharmaceutical products for federal medical supply needs. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB24D2102Indefinite Delivery Contract
- SPE2DB24D2102-SPE2DB25FJJTXDelivery Order
The Defense Logistics Agency awarded a $14,320.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3mL insulin pens. The award is not set-aside and will be completed by September 23, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems through its extensive portfolio of medical product deliveries. The parent IDC enables the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and other critical commodities. This particular delivery order for insulin supplies reflects the company's role in supporting the healthcare needs of Defense Health Agency beneficiaries and other government medical systems through competitively awarded, firm fixed-price transactions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 9/22/25 |